Cell Cycle, Cancer, Cell Death Flashcards
G1 cyclins include
C, D1
S cyclins include
Cyclin A
G2/M cyclins include
B 1-2
Cyclin H
Constitutive expression
Cdk4/Cdk6
Binds with cyclin D
Phosphorylation of retinoblastoma susceptibility protein (pRb) in G1
Triggers passage of the restriction point, and cyclin E synthesis in some cells
Cdk2
Binds with cyclin E and A
Triggers G1–>S transition
Cdk1
Binds with Cyclin B, triggers G2–>M transition
Cdk activation
Cdks have 3 phosphate binding sites. Phosphorylation of one of these sites activates it, while phosphorylation of the other 2 sites inactivates it.
The complex must be phosphorylated on the first site, and dephosphorylated (by protein phosphatase cdc25) on the other two sites to be active
Cdc25A phosphatase
Acts on Cdk1, Cdk2
Promotes G1–>S and G2–>M transitions
Cdc25B phosphatase
Acts on Cdk1
Promotes G2–>M transition
Cdc25C phosphatase
Acts on Cdk1
Promotes G2–>M transition
Dephosphorylates Cdk1 complexed to cyclins A/B
CKI: p21
Induced by p53 tumor suppressor. Cell cycle arrest after DNA damage. Binds most Cdk-cyclin complexes
CKI: p27
Cell cycle arrest in response to growth suppressors like TGF-b
Binds Most Cdk cyclin complexes
INK4: p16
Cooperates with retinoblastoma susceptibility protein pRb in growth regulation. Cell cycle arrest in senescence.
What are the common substrates for all INK4 cyclin inhibitors
Cdk4 and Cdk6
What is the predominant cyclin during G1 phase
Nuclear D1
Explain cyclin/Cdk activity during the G1/S transition
E-CDK2 complexes hyperphosphorylate pRb, which liberates E2F transcription factors from pRb control, enabling E2Fs to trigger increased transcription of the cyclin E and E2F1 genes. This leads to synthesis of more cyclin E and formation of more E-CDK2 complexes, which then amplify the process by hyperphosphorylating more pRb. E2F1 amplifies its own activity